Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience.
Tillmann HL, Hadem J, Leifeld L, Zachou K, Canbay A, Eisenbach C, Graziadei I, Encke J, Schmidt H, Vogel W, Schneider A, Spengler U, Gerken G, Dalekos GN, Wedemeyer H, Manns MP.
Tillmann HL, et al. Among authors: leifeld l.
J Viral Hepat. 2006 Apr;13(4):256-63. doi: 10.1111/j.1365-2893.2005.00695.x.
J Viral Hepat. 2006.
PMID: 16611192
Clinical Trial.